Intrommune Therapeutics
Get Full AccessDescription
- Intrommune Therapeutics is a specialty biopharmaceutical company located in New York, NY. Intrommune is developing a revolutionary new treatment platform for food allergies that is safe, effective and convenient. Intrommunes first product is a therapy for patients who suffer from peanut allergy. Intrommune is developing the oral mucosal immunotherapy (OMIT) platform for food allergies. It is a long-term solution for the 220 million, including 9 million U.S. adults and 6 million U.S. children, who suffer from this life-altering condition.
-
Headquarters: , , New York, United States
More -
Phone Number:
-
Website: https://www.intrommune.com
-
Employees:7
-
Revenue:$1 - 10M
-
Legal Name:Intrommune Therapeutics
-
Intrommune Therapeutics's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Frequently Asked Questions regarding Intrommune Therapeutics
-
What is Intrommune Therapeutics's official website?
Intrommune Therapeutics's official website is https://www.intrommune.com
-
What is Intrommune Therapeutics's Revenue?
Intrommune Therapeutics's revenue is $1 - 10M
-
What is Intrommune Therapeutics's NAICS code?
Intrommune Therapeutics's NAICS code is 541713
-
How many employees are working in Intrommune Therapeutics
Intrommune Therapeutics has 7 employees
-
What is Intrommune Therapeutics's Industry?
Intrommune Therapeutics is in the industry of Biotechnology
-
Who is Intrommune Therapeutics's CEO?
Intrommune Therapeutics's CEO is Michael Nelson
-
Who is Intrommune Therapeutics's Chief Strategy Officer?
Intrommune Therapeutics's Chief Strategy Officer is Sergi Trilla
-
Who is Intrommune Therapeutics's Chief Commercial Officer?
Intrommune Therapeutics's Chief Commercial Officer is Stuart Loesch

